OBJECTIVE:
In this open trial, Panax ginseng, a serotonin and norepinephrine reuptake inhibitor, actually used as an antidepressant, has been investigated for its efficacy in the treatment of attention-deficit hyperactivity disorder (ADHD) patients.
METHOD:
Three 14-17-year-old male psychiatric outpatients, diagnosed with ADHD disattention type have been rated at baseline and while taking Panax ginseng to determine its efficacy as a treatment for ADHD. Improvement was determined using comparisons of Conners' parent ratings.
RESULTS:
Patients' mean scores improved for Conners' hyperactivity, inattention, and immaturity factors.
CONCLUSIONS:
Although the sample size is very small and generalization is very difficult, this observation indicates that Panax ginseng may be a slightly effective treatment for ADHD.